Capstan Therapeutics clinical trials
Acquired by AbbVie, Aug 19, 2025 · source ↗
The registry lists 1 studies whose lead sponsor is Capstan Therapeutics. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 16, 2026.
Before and after it joined AbbVie
- First submitted before Capstan Therapeutics became part of AbbVie
- 1
- First submitted after Capstan Therapeutics became part of AbbVie
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Capstan Therapeutics1 study
Something wrong with this grouping? Tell us on the AbbVie page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All AbbVie studies →
- A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE)RecruitingNCT06917742Phase 1
Sponsor listed in the registry: Capstan Therapeutics · First submitted before Capstan Therapeutics became part of AbbVie